This page provides federal resources that are helpful during emergencies and disasters. We also created Medicaid & CHIP disaster preparedness toolkits to provide states and territories with additional disaster-related information.
Federal Disaster Resources
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Rhode Island for multiple section 1135 flexibilities on March 25, 2020 and subsequent approvals on May 18, 2020. Your follow-up communication to CMS on February 9, 2021 detailed additional federal requirements that also pose issues or challenges for the health care delivery system in Rhode Island and requested a waiver or modification of those additional requirements.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Rhode Island for multiple section 1135 flexibilities on March 25, 2020 Your follow-up communication to CMS on January 13, 2021 indicated Rhode Island’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Texas for multiple section 1135 flexibilities on March 30, 2020. Your follow-up communication to CMS on January 14, 2021 indicated Texas’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the Territory of the United States Virgin Islands for multiple section 1135 flexibilities on April 7, 2020. Your follow-up communication to CMS on January 13, 2021 indicated the United State Virgin Islands’ response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Washington for multiple section 1135 flexibilities on March 19, 2020. Your follow-up communication to CMS on January 19, 2021 indicated Washington’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Virginia for multiple section 1135 flexibilities on May 19, 2020. Your follow-up communication to CMS on December 31, 2020 detailed additional federal requirements that also pose issues or challenges for the health care delivery system in Virginia and requested a waiver or modification of those additional requirements.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Utah for multiple section 1135 flexibilities on April 10, 2020. Your follow-up communication to CMS on January 15, 2021, indicated Utah’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of New Jersey for multiple section 1135 flexibilities on March 23, 2020 Your follow-up communication to CMS on January 14, 2021 indicated New Jersey’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Michigan for multiple section 1135 flexibilities on April 6, 2020. Your follow-up communication to CMS on January 14, 2021 indicated Michigan’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Virginia for multiple section 1135 flexibilities on May 19, 2020. Your follow-up communication to CMS on January 22, 2021 indicated Virginia's response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
Show
entries